Clinical Trial Update: Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH [Phase 4]

View source ↗

Summary

Phase 4 study assessing riociguat's effects on right ventricular size and function in pulmonary arterial hypertension and chronic thromboembolic pulmonary hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: Heidelberg University | Conditions: Primary Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension | Phase 4 | Status: TERMINATED